955 results on '"Gunn, Roger N."'
Search Results
102. Modeling sensitization to stimulants in humans: an [(sup 11) 11C]raclopride/positron emission tomography study in healthy men
103. A Generalised Spatio-Temporal Registration Framework for Dynamic PET Data: Application to Neuroreceptor Imaging
104. Statistical maps for EEG dipolar source localization
105. Spatial-temporal Pharmacokinetic Model Based Registration of 4D Brain PET Data
106. PET-SORTEO: a Monte Carlo-based simulator with high count rate capabilities
107. Kinetic Analysis of Drug–Target Interactions with PET for Characterization of Pharmacological Hysteresis
108. Evaluation of [O-methyl-11C]RS-15385-197 as a positron emission tomography radioligand for central α2-adrenoceptors
109. Orbitofrontal Connectivity with Resting-State Networks Is Associated with Midbrain Dopamine D3 Receptor Availability
110. Combining PET Biodistribution and Equilibrium Dialysis Assays to Assess the Free Brain Concentration and BBB Transport of CNS Drugs
111. Positron emission tomography molecular imaging for drug development
112. Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans
113. An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28
114. Acute acetate administration increases endogenous opioid levels in the human brain: A [11C]carfentanil molecular imaging study
115. Prediction of Repeat-Dose Occupancy from Single-Dose Data: Characterisation of the Relationship between Plasma Pharmacokinetics and Brain Target Occupancy
116. Characterising the temporal relationship between Aβ and tau accumulation in AD using in vivo imaging data
117. A multisite analysis of the concordance between visual image interpretation and quantitative analysis of [ 18 F]flutemetamol PET images
118. Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme: Translation from rat to human
119. Amyloid IQ : An advanced analytical algorithm to quantify amyloid‐PET [ 18 F]NAV4694 scans
120. Consensus Recommendations on the Use of18F-FDG PET/CT in Lung Disease
121. Test–retest variability and reference region-based quantification of 18F-BCPP-EF for imaging mitochondrial complex I in the human brain
122. Mitochondrial Complex 1, Sigma 1, and Synaptic Vesicle 2A in Early Drug‐Naive Parkinson's Disease
123. Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation
124. PBR28, PBR06 and PBR111 bind two distinct TSPO sites in human brain tissue
125. Evaluation of the in vivo ED50 for the PET Radioligand, [11C]GSK-215083, in Papio anubis
126. A combined diffusion tensor imaging (DTI) and [11C]-(+)-PHNO positron emission tomography (PET) study to quantify dopamine D3/D2 receptors in pallidum
127. PET imaging of dopamine D3 receptors in humans with [11C]-(+)-PHNO: dissection of PHNO signal using two highly selective D3 antagonists
128. Awake nonhuman primate brain PET imaging without head restraint
129. Real-Time Adaptive Sequential Design for Optimal Acquisition of Arterial Spin Labeling MRI Data
130. Imaging Cortical Dopamine D1 Receptors Using [11C]NNC112 and Ketanserin Blockade of the 5-HT2A Receptors
131. Measuring Drug Occupancy in the Absence of a Reference Region: The Lassen Plot Re-Visited
132. Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals
133. PET studies in drug development: Methodological considerations
134. Wavelet variance components in image space for spatiotemporal neuroimaging data
135. Statistical estimation with Kronecker products in positron emission tomography
136. Kinetic modelling of dissolution dynamic nuclear polarisation 13C magnetic resonance spectroscopy data for analysis of pyruvate delivery and fate in tumours.
137. JOP517953_Supplementary_material – Supplemental material for Characterising the plasma-target occupancy relationship of the neurokinin antagonist GSK1144814 with PET
138. sj-pdf-1-jcb-10.1177_0271678X20928149 - Supplemental material for Test–retest variability and reference region-based quantification of 18F-BCPP-EF for imaging mitochondrial complex I in the human brain
139. JCB905433 Supplemental Material2 - Supplemental material for Guidelines for the content and format of PET brain data in publications and archives: A consensus paper
140. Optimal design of pulsed arterial spin labeling MRI experiments
141. Relationship between neuromelanin and dopamine terminals within the Parkinson’s nigrostriatal system
142. Non-invasive measurement of left ventricular volumes and function by gated positron emission tomography
143. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
144. Tracer Kinetic Modeling via Basis Pursuit
145. Modeling Sensitization to Stimulants in Humans: An [11C]Raclopride/Positron Emission Tomography Study in Healthy Men
146. Analysis of Functional Imaging Data Sets via Functional Segmentation
147. Imaging Activated Microglia in the Aging Human Brain
148. Small Animal PET Enables Parametric Mapping of Saturation Kinetics at the 5-HT1A Receptor
149. Guidelines for the content and format of PET brain data in publications and archives:A consensus paper
150. Serotonin release measured in the human brain:a PET study with [11C]CIMBI-36 and d-amphetamine challenge
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.